Naturally Occurring PCSK9 Inhibitors

PCSK9 Inhibitors

Alirocumab and evolocumab are monoclonal antibodies that block proprotein convertase subtilisin/kexin type 9 (PCSK9), a circulating protein that degrades low-density lipoprotein (LDL) receptors. These therapies increase LDL receptors on the cell surface and reduce plasma LDL cholesterol. Both therapies are approved to lower LDL cholesterol, a causative agent for atherosclerotic cardiovascular d...

Naturally occurring ehrlichiosis in Egyptian dogs

Canine ehrlichiosis has emerged as one of the most clinically important tick-borne diseases affecting dogs. Eighty-five naturally infected dogs have been investigated, the most consistent clinical signs recorded were fever, emaciation and lymphoadenopathy, anemia, monocytosis, thrompocytopenia, hypoalbuminemia, elevation in liver enzymes and total bilirubin were the most remarkable changes asso...

Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

Synthesis and biological activity of naturally occurring α-glucosidase inhibitors.

In addition to their clinical importance in the treatment of type II diabetes, a-glucosidase inhibitors have attracted considerable attention from the synthetic community because of their profound effect on an array of cellular processes, including N-linked glycoprotein processing and maturation, oligosaccharide metabolism, and cell–cell and cell–virus recognition. Over the past decade, a numbe...

Naturally occurring enolethers

Enolethers are a group of reactive compounds also occurring in the nature and displaying different kinds of activities, such as antifungal, antibacterial, nematocidal, cytostatic, cytotoxic, phytotoxic, nematicidal, antipyretic, hypotensive, analgesic, antitussive, depresant, anticancerogenic and antiviral.